Navigation Links
CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth
Date:3/2/2009

SUNNYVALE, Calif., March 2 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today significant growth in CyberKnife lung cancer treatments in calendar year 2008. The number of lung cancer patients treated with CyberKnife radiosurgery in the United States grew 52 percent from calendar year 2007 to 2008 and 43 percent worldwide. Additionally the overall number of patients treated with CyberKnife radiosurgery grew to more than 60,000 patients - a 14 percent increase from calendar year 2007 to 2008, demonstrating the increasing awareness and continued rapid adoption of CyberKnife radiosurgery, with lung being the leading extracranial indication by utilization in calendar year 2008.

The increasing interest in CyberKnife radiosurgery for lung tumors was further validated at this year's Society of Thoracic Surgeons (STS) Meeting in San Francisco. Recent publication of several clinical papers describing the benefits of the CyberKnife System's accurate delivery of high dose radiation to treat lung cancer has helped to raise the profile of the CyberKnife System, particularly amongst this group of physicians.

Discussions by leading thoracic surgeons, such as James Luketich, M.D., Chief of The Heart, Lung and Esophageal Surgery Institute at the University of Pittsburgh Medical Center highlighted the efficacy and resulting increased demand for CyberKnife treatments for lung cancer patients, while also emphasizing the need for thoracic surgeons to increase their awareness and involvement with CyberKnife radiosurgery. Dr. Luketich's points were further underscored by Richard Whyte, M.D., Professor of Thoracic Surgery at Stanford University School of Medicine. During his STS University session, Dr. Whyte reviewed the importance of the CyberKnife System
'/>"/>

SOURCE Accuray Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Morse CyberKnife CEO James G. Schwade, M.D. Announces Non-Surgical Treatment With CyberKnife Radiosurgery for Prostate Cancer
2. New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times
3. M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
4. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
5. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
6. Next Generation Proton Therapy System for Cancer Treatment Set for Release This Year
7. New Cancer Treatment Stops Aggressive Sarcomas
8. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
9. Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads
10. Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival
11. Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential ... ("Advaxis" or the "Company") (NASDAQ: ADXS ), ... to shareholders. On January 21, 2015, an ... Advaxis had misrepresented the clinical data for its ADXS-HPV ...
(Date:1/23/2015)... Idaho , Jan. 23, 2015  Now available for ... No. 7,849,611) support that prevents ankle sprains by cushioning ... brace, it fits securely around the outside of any ... mobility & comfort while still offering protection against sprains. ...
(Date:1/23/2015)... Jan. 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ... the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with ... and provides an update for shareholders detailing why a "YES" ... Dear Shareholders, As we reflect upon ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... N.J., April 19, 2007 /PRNewswire-FirstCall/ --,VioQuest Pharmaceuticals, ... on acquiring, developing and,commercializing targeted cancer compounds, ... 002, a direct inhibitor of Akt,activation for ... data was presented in a poster at ...
... Top-Line Phase III Results for,Keppra® as Adjunctive ... from One Month to Less than Four ... 20, 2007 - UCB today announced,positive top-line ... placebo-controlled study evaluating the,efficacy and tolerability of ...
Cached Medicine Technology:VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 2UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 3UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 4UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 5
(Date:1/22/2015)... 2015 The U.S. Pharmacopeial Convention is ... of Clinical Pharmacy Services at North Carolina State’s College ... the 2015 Beal Award for Distinguished Volunteer Service—the organization’s ... on the contributions of volunteer experts to direct its ...
(Date:1/22/2015)... 2015 The City of West Hollywood hosted a ... commemorate the 42nd anniversary of the Supreme Court decision Roe v. ... 42 years since the Roe vs. Wade decision and the fight ... as ever,” said City of West Hollywood Councilmember Abbe Land. “We ...
(Date:1/22/2015)... 22, 2015 Padre Murphy's and Owner Tom ... Pro Player Health Alliance (PPHA). The PPHA's passion ... getting everyone, including NFL greats, treated for obstructive sleep apnea ... groups supporting the cause in the valley. The most recent ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering ... follow it on Facebook, Twitter, and Pinterest. The fans will ... draws a lottery every week. , Moreover, the company has ... Click Angelweddingdress homepage for more information. , ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
... ... Feisal Nanji of Techumen were selected to serve on the prestigious Certification Commission for ... sole public mission of accelerating the adoption of robust, interoperable health information technology by ... ...
... Novo Nordisk product previously reported as stolen in North Carolina ... , Three lots of 10 ml vials of insulin, ... injection), were taken in the original theft and identifiable by ... A vial or vials of stolen insulin from lot XZF0037 ...
... , , LOS ANGELES, June 12 After the ... and actresses in the adult entertainment industry recently tested positive for ... and rally Monday, June 15th at 9:00pm at porn ... Sunset Strip in West Hollywood (8920 Sunset Blvd.) to call for ...
... , WASHINGTON, June 12 The following is a ... Findley on passage of the Family Smoking Prevention and ... Association heartily commends Congress for passing the Family Smoking ... by the Senate and today by the House of ...
... and similar meds should watch for such problems , ... and Drug Administration on Friday requested that the makers ... agonists place a "precaution" on the drugs, labeling, warning ... in question include the blockbuster medication Singulair (montelukast), ...
... antidepressants and other medications raise risk, study says , FRIDAY, ... men turning 50: After their half-century mark, about 4 percent ... the most common eye conditions and reasons for seeing an ... eye disease causes a persistent dryness, itching or burning sensation ...
Cached Medicine News:Health News:Health Information Security: CCHIT and Techumen 2Health News:Novo Nordisk Warns Customers About Stolen Insulin 2Health News:Novo Nordisk Warns Customers About Stolen Insulin 3Health News:Protest: AHF to Renew Call for California 'Condoms in Porn' Law at Larry Flynt's Hustler/Hollywood Store 2Health News:Statement by American Dental Association President Dr. John S. Findley on Passage of the Family Smoking Prevention and Tobacco Control Act 2Health News:Asthma Drugs Get 'Precaution' Labeling for Possible Psychiatric Side Effects 2Health News:Asthma Drugs Get 'Precaution' Labeling for Possible Psychiatric Side Effects 3Health News:Asthma Drugs Get 'Precaution' Labeling for Possible Psychiatric Side Effects 4Health News:For Men Over 50, Odds of Eye Discomfort Increases 2
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... Finnpipette Techpette combines form and ... pipette. Advanced pipetting technology, plus ... quality, safety, comfort and accuracy. ... range is an important safety ...
A Biplane Pediatric TEE transducer....
Super High Density, multi-frequency, convex array transducer for scanning during craniotomies. Same footprint as the UST-987-7.5 but with stronger penetration for deep cavernous tumors and other deep...
Medicine Products: